Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ineke van Straaten"'
Autor:
Dirk Mekkes, Khalequ Zaman, Yunus, Robert Kingma, Ineke van Straaten, Xandra Bouwstra, Bhagwat Gunale, Prasad S. Kulkarni
Publikováno v:
Vaccine. 38:707-708
Autor:
Khalequ Zaman, Prasad S. Kulkarni, Bhagwat Gunale, Robert Kingma, Yunus, Xandra Bouwstra, Ineke van Straaten, Dirk Mekkes
Publikováno v:
Vaccine. 37(31)
Background Poliomyelitis infection continues to be endemic in few countries despite rigorous efforts for eradication. A new Bivalent Oral Polio Vaccine (BBio bOPV) was tested in a Phase III Clinical study. Methods An observer blind, randomized, contr
Autor:
Germie P. J. M. van den Dobbelsteen, Patricia Kaaijk, Bas van de Waterbeemd, Elmieke P.J. Boot, Harry van Dijken, Lonneke Levels, Ineke van Straaten
Publikováno v:
Vaccine. 31(7)
Background An improved nonavalent PorA native outer membrane vesicle vaccine was developed with intrinsic adjuvating activity due to presence of less-toxic (lpxL1) LPS. In the present study, the safety and immunogenicity of this next-generation NonaM
Autor:
Coenraad F.M. Hendriksen, Huib J. M. Van De Donk, Arnoud M. Akkermans, Ineke van Straaten-van de Kappelle, Arno van der Ark
Publikováno v:
Biologicals. 22:233-242
Abstract. The current potency test for pertussis vaccines, the mouse protection test (MPT), has many disadvantages. However, no alternative is yet available. The purpose of this study is to develop a serological alternative for the MPT based on in vi
Autor:
Emmanuel J.H.J. Wiertz, Huib J. M. Van De Donk, F.R. Marsman, Ineke van Straaten-van de Kappelle, Dominique J.M. Borsboom, J.G. Kreeftenberg
Publikováno v:
Biologicals. 20:277-282
For the safety testing of pertussis vaccine, many in vivo assays have been developed, but none of these assays, except the Mouse Weight Gain (MWG)-test, are obligatory. Leukocytosis Promoting Factor (LPF) test, performed in mice, is one of the tests
Autor:
Coen Beuvery, Jan van den IJssel, Marcel Thalen, Dirk E. Martens, Dennis Jansen, Arno van der Ark, Johannes Tramper, Ineke van Straaten
Publikováno v:
Vaccine, 26(5), 653-663
Vaccine 26 (2008) 5
Vaccine 26 (2008) 5
Although Europe, Canada and the US have switched from cellular to acellular pertussis vaccines, most developing countries will continue to use the more cost effective cellular vaccine. Consistency of production however is the typical problem inherent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ddf155268303ab251710b97d88bc5d
https://research.wur.nl/en/publications/improving-the-cellular-pertussis-vaccine-increased-potency-and-co
https://research.wur.nl/en/publications/improving-the-cellular-pertussis-vaccine-increased-potency-and-co
Autor:
Coenraad F.M. Hendriksen, Johan van der Gun, F.R. Marsman, Ineke van Straaten-van de Kappelle, Huib J. M. Van De Donk
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 25(1)
A collaborative study has been carried out to establish the precision and accuracy of five test systems for the assessment of the toxicity of whole cell pertussis vaccine. To this end, six vaccines, including both "normal" and "abnormal" products wit
Autor:
Carla C. A. M. Peeters, Ivo J.T.M Claassen, Dominique Borsboom, Peter van der Ley, Ineke van Straaten, Arno van der Ark, Jan Poolman, Paul J.M. Roholl, Betsy Kuipers, Jolanda Robert, Jolanda Meylis, Hans Brons
Publikováno v:
Vaccine. 14(10)
An experimental serogroup B meningococcal vaccine was prepared from two genetically engineered strains; each expressing three different class 1 outer membrane proteins (OMPs) (PorA). The two strains expressed the subtypes P1.7,16;P1.5,2;P1.19,15 and
Publikováno v:
Biologicals. 21:17-18